News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Thomas C. Fenter, MD

Articles by Thomas C. Fenter, MD

Dutasteride vs Finasteride: Assessment of Differences in Acute Urinary Retention Rates and Surgical Risk Outcomes in an Elderly Population Aged ≥65 Years

ByThomas C. Fenter, MD,E. Anne Davis, PharmD, MS,Manan B. Shah, PharmD, PhD,Pei-Jung Lin, PhD

May 1st 2008

Finasteride Versus Dutasteride: A Real-world Economic Evaluation

ByThomas C. Fenter, MD,M. Chris Runken, PharmD,Libby Black, PharmD,Michael Eaddy, PharmD, PhD

February 1st 2007

An Assessment of the Diagnosed Prevalence of Diseases in Men 50 Years of Age or Older

ByMuta M. Issa, MD, MBA,Thomas C. Fenter, MD,Libby Black, PharmD,Amy L. Grogg, PharmD,Eric J. Kruep, PharmD, MS

March 1st 2006

The Cost of Treating the 10 Most Prevalent Diseases in Men 50 Years of Age and Older

ByThomas C. Fenter, MD,Michael James Naslund, MD, MBA,Manan B. Shah, PharmD, PhD,Michael T. Eaddy, PharmD, PhD,Libby Black, PharmD

March 1st 2006

Latest Updated Articles

Trending on AJMC

5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug

GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis

Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care

Sarcoma Gene Signature May Predict Who Benefits From Pazopanib

ICER Draft Flags High Cost of New Hypertension Drug Class